Vorinostat Completed Phase 1 / 2 Trials for Children With Relapsed Solid Tumor, Lymphoma or Leukemia Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs